SC 13G Filing

Company

Coeptis Therapeutics Holdings, Inc.

Filed

December 28, 2020

Accession Number

0000905148-20-001310

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →